GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71−0.33 (-16.42%)
Close on Nov 13, 2026Market cap $717.73KP/E –Yield –
GeoVax Labs operating margin
Operating margin is operating income as a percentage of revenue.
GeoVax Labs's operating margin for the twelve months ending Mar 31, 2026 was -2523.4%. For fiscal 2025 it was -869.3%, against -635.8% the year before. The highest annual figure on record is -154.5% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -869.3% | −233.5 |
| FY2024 | Dec 31, 2024 | -635.8% | +16571.6 |
| FY2022 | Dec 31, 2022 | -17207.5% | −12344.8 |
| FY2021 | Dec 31, 2021 | -4862.7% | −4708.3 |
| FY2020 | Dec 31, 2020 | -154.5% | +47.3 |
| FY2019 | Dec 31, 2019 | -201.8% | +64.3 |
| FY2018 | Dec 31, 2018 | -266.1% | −63.8 |
| FY2017 | Dec 31, 2017 | -202.2% | +192.7 |
| FY2016 | Dec 31, 2016 | -394.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -635.8% | +1047.8 |
| Q1 FY2025 | Mar 31, 2025 | -330.2% | +2648.0 |
| Q4 FY2024 | Dec 31, 2024 | -965.3% | +7366.1 |
| Q3 FY2024 | Sep 30, 2024 | -209.9% | +6206.2 |
| Q2 FY2024 | Jun 30, 2024 | -1683.6% | +181.5 |
| Q1 FY2022 | Mar 31, 2022 | -2978.2% | −1561.7 |
| Q4 FY2021 | Dec 31, 2021 | -8331.5% | −7800.1 |
| Q3 FY2021 | Sep 30, 2021 | -6416.1% | −6311.0 |
| Q2 FY2021 | Jun 30, 2021 | -1865.1% | −1763.4 |
| Q1 FY2021 | Mar 31, 2021 | -1416.5% | −1333.4 |
| Q4 FY2020 | Dec 31, 2020 | -531.4% | −311.3 |
| Q3 FY2020 | Sep 30, 2020 | -105.0% | +22.8 |
| Q2 FY2020 | Jun 30, 2020 | -101.7% | +209.8 |
| Q1 FY2020 | Mar 31, 2020 | -83.1% | +109.5 |
| Q4 FY2019 | Dec 31, 2019 | -220.1% | −8.2 |
| Q3 FY2019 | Sep 30, 2019 | -127.8% | +63.2 |
| Q2 FY2019 | Jun 30, 2019 | -311.5% | +372.7 |
| Q1 FY2019 | Mar 31, 2019 | -192.6% | +88.9 |
| Q4 FY2018 | Dec 31, 2018 | -211.9% | +76.4 |
| Q3 FY2018 | Sep 30, 2018 | -191.0% | +47.0 |
| Q2 FY2018 | Jun 30, 2018 | -684.2% | −537.1 |
| Q1 FY2018 | Mar 31, 2018 | -281.5% | −95.9 |
| Q4 FY2017 | Dec 31, 2017 | -288.3% | – |
| Q3 FY2017 | Sep 30, 2017 | -238.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -147.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -185.5% | – |
See a number that looks wrong?